Woodline Partners’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77.9K | Hold |
69,576
| – | – | ﹤0.01% | 909 |
|
|
2025
Q1 | $80K | Buy |
69,576
+2,317
| +3% | +$2.67K | ﹤0.01% | 888 |
|
|
2024
Q4 | $411K | Hold |
67,259
| – | – | ﹤0.01% | 858 |
|
|
2024
Q3 | $1.11M | Sell |
67,259
-7,741
| -10% | -$128K | 0.01% | 502 |
|
|
2024
Q2 | $515K | Hold |
75,000
| – | – | ﹤0.01% | 496 |
|
|
2024
Q1 | $724K | Hold |
75,000
| – | – | 0.01% | 460 |
|
|
2023
Q4 | $623K | Hold |
75,000
| – | – | 0.01% | 416 |
|
|
2023
Q3 | $626K | Hold |
75,000
| – | – | 0.01% | 480 |
|
|
2023
Q2 | $692K | Sell |
75,000
-78,825
| -51% | -$728K | 0.01% | 512 |
|
|
2023
Q1 | $2.11M | Buy |
153,825
+3,825
| +3% | +$52.6K | 0.03% | 408 |
|
|
2022
Q4 | $2.55M | Sell |
150,000
-50,047
| -25% | -$851K | 0.03% | 439 |
|
|
2022
Q3 | $4.55M | Hold |
200,047
| – | – | 0.06% | 310 |
|
|
2022
Q2 | $3.61M | Sell |
200,047
-203,354
| -50% | -$3.67M | 0.06% | 307 |
|
|
2022
Q1 | $10.8M | Hold |
403,401
| – | – | 0.18% | 166 |
|
|
2021
Q4 | $11.8M | Sell |
403,401
-165,608
| -29% | -$4.86M | 0.17% | 162 |
|
|
2021
Q3 | $37.4M | Sell |
569,009
-176,384
| -24% | -$11.6M | 0.61% | 35 |
|
|
2021
Q2 | $62M | Buy |
745,393
+314,710
| +73% | +$26.2M | 1.16% | 15 |
|
|
2021
Q1 | $33M | Sell |
430,683
-109,733
| -20% | -$8.42M | 0.73% | 37 |
|
|
2020
Q4 | $47.7M | Buy |
540,416
+450,038
| +498% | +$39.7M | 1.27% | 19 |
|
|
2020
Q3 | $6.67M | Buy |
+90,378
| New | +$6.67M | 0.22% | 109 |
|